Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer

Published:2009-07 Issue:2 Volume:71 Page:177-182
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Tomoda Keishiro,Ohkoshi Takumi,Hirota Keiji,Sonavane Ganeshchandra S.,Nakajima Takehisa,Terada Hiroshi,Komuro Masahito,Kitazato Kenji,Makino Kimiko

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference24 articles.

1. Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549

2. New drugs in the treatment of non-small cell lung cancer

3. Development of Inhalational Agents for Oncologic Use

4. Aerosol delivery of liposomal all- trans -retinoic acid to the lungs

5. Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO 2 -enriched air: pharmacokinetic studies

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine;Pharmaceuticals;2024-08-12

2. DEVELOPMENT AND EVALUATION OF PHARMACEUTICALLY EQUIVALENT LEVOSALBUTAMOL DRY POWDER INHALER WITH INCREASED IN VITRO DEPOSITION;INDIAN DRUGS;2024-06-28

3. Formulation of Folate Receptor-Targeted Silibinin-Loaded Inhalable Chitosan Nanoparticles by the QbD Approach for Lung Cancer Targeted Delivery;ACS Omega;2024-02-24

4. Long-acting inhaled medicines: Present and future;Advanced Drug Delivery Reviews;2024-01

5. Emerging delivery approaches for targeted pulmonary fibrosis treatment;Advanced Drug Delivery Reviews;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3